Dlk1/FA1 is a novel endocrine regulator of bone and fat mass and its serum level is modulated by growth hormone

Endocrinology

Volumn 148, Issue 7, 2007, Pages 3111-3121

  Abdallah, Basem M ^a   Ding, Ming ^a   Jensen, Charlotte H ^b   Ditzel, Nicholas ^a   Flyvbjerg, Allan ^c   Jensen, Thomas G ^d   Dagnæs Hansen, Frederik ^c   Gasser, Jürg A ^e   Kassem, Moustapha ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d JOHN F KENNEDY INSTITUTE   (Denmark)

^e NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA LIKE 1 PROTEIN; FAT; FETAL ANTIGEN 1; GENE PRODUCT; GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE MASS; CONTROLLED STUDY; DOSE RESPONSE; ENDOCRINE SYSTEM; GENE TRANSFER; GROWTH HORMONE BLOOD LEVEL; HYDRODYNAMICS; HYPOPHYSECTOMY; HYPOPHYSIS; IN VIVO STUDY; MALE; MODULATION; MOUSE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WEIGHT REDUCTION;

ANIMALS; BODY WEIGHT; BONE AND BONES; BONE DENSITY; FATS; GENE TRANSFER TECHNIQUES; GROWTH HORMONE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED BALB C; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34347238966     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0171     Document Type: Article

References (61)

1. Reid IR 2002 Relationships among body mass, its components, and bone. Bone 31:547-555
2. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM 1995 Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332:767-773
3. von Mach MA, Stoeckli R, Bilz S, Kraenzlin M, Langer I, Keller U 2004 Changes in bone mineral content after surgical treatment of morbid obesity. Metabolism 53:918-921
4. Jensen CH, Meyer M, Schroder HD, Kliem A, Zimmer J, Teisner B 2001 Neurons in the monoaminergic nuclei of the rat and human central nervous system express FA1/dlk. Neuroreport 12:3959-3963
5. Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, Kassem M 2001 Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2:165-171
6. Kassem M, Kristiansen M, Abdallah BM 2004 Mesenchymal stem cells: cell biology and potential use in therapy. Basic Clin Pharmacol Toxicol 95:209-214
7. Gimble JM, Zvonic S, Floyd ZE, Kassem M, Nuttall ME 2006 Playing with bone and fat. J Cell Biochem 98:251-266
8. Douchi T, Oki T, Nakamura S, Ijuin H, Yamamoto S, Nagata Y 1997 The effect of body composition on bone density in pre- and postmenopausal women. Maturitas 27:55-60
9. Barrett-Connor E, Kritz-Silverstein D 1996 Does hyperinsulinemia preserve bone? Diabetes Care 19:1388-1392
10. Mukherjee A, Murray RD, Shalet SM 2004 Impact of growth hormone status on body composition and the skeleton. Hormone Res 62(Suppl 3):35-41
11. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G 2000 Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197-207
12. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G 2002 Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305-317
13. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, Jansson JO 2002 Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8:75-79
14. Abdallah BM, Jensen CH, Gutierrez G, Leslie GQ, Jensen TG, Kassem M 2004 Regulation of human skeletal stem cells differentiation by Dlk1/Pref-1. J Bone Miner Res 19:841-852
15. Lee K, Villena JA, Moon YS, Kim KH, Lee S, Kang C, Sul HS 2003 Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1). J Clin Invest 111:453-461
16. Moon YS, Smas CM, Lee K, Villena JA, Kim KH, Yun EJ, Sul HS 2002 Mice lacking paternally expressed Pref-1/Dlk1 display growth retardation and accelerated adiposity. Mol Cell Biol 22:5585-5592
17. Manzoni MF, Pramparo T, Stroppolo A, Chiaino F, Bosi E, Zuffardi O, Carrozzo R 2000 A patient with maternal chromosome 14 UPD presenting with a mild phenotype and MODY. Clin Genet 57:406-408
18. Carlsson C, Tornehave D, Lindberg K, Galante P, Billestrup N, Michelsen B, Larsson LI, Nielsen JH 1997 Growth hormone and prolactin stimulate the expression of rat preadipocyte factor-1/delta-like protein in pancreatic islets: molecular cloning and expression pattern during development and growth of the endocrine pancreas. Endocrinology 138:3940-3948
19. Crameri RM, Langberg H, Magnusson P, Jensen CH, Schroder HD, Olesen JL, Suetta C, Teisner B, Kjaer M 2004 Changes in satellite cells in human skeletal muscle after a single bout of high intensity exercise. J Physiol (Lond) 558:333-340
20. Tanimizu N, Tsujimura T, Takahide K, Kodama T, Nakamura K, Miyajima A 2004 Expression of Dlk/Pref-1 defines a subpopulation in the oval cell compartment of rat liver. Gene Expr Patterns 5:209-218
21. Costaglioli P, Come C, Knoll-Gellida A, Salles J, Cassagne C, Garbay B 2001 The homeotic protein dlk is expressed during peripheral nerve development. FEBS Lett 509:413-416
22. Moore KA, Pytowski B, Witte L, Hicklin D, Lemischka IR 1997 Hematopoietic activity of a stromal cell transmembrane protein containing epidermal growth factor-like repeat motifs. Proc Natl Acad Sci USA 94:4011-4016
23. Hackney JA, Charbord P, Brunk BP, Stoeckert CJ, Lemischka IR, Moore KA 2002 A molecular profile of a hematopoietic stem cell niche. Proc Natl Acad Sci USA 99:13061-13066
24. Jensen CH, Teisner B, Hojrup P, Rasmussen HB, Madsen OD, Nielsen B, Skjodt K 1993 Studies on the isolation, structural analysis and tissue localization of fetal antigen 1 and its relation to a human adrenal-specific cDNA, pG2. Hum Reprod 8:635-641
25. Wang Y, Sul HS 2006 Ectodomain shedding of preadipocyte factor 1 (Pref-1) by tumor necrosis factor α converting enzyme (TACE) and inhibition of adipocyte differentiation. Mol Cell Biol 26:5421-5435
26. Jensen CH, Krogh TN, Stoving RK, Holmskov U, Teisner B 1997 Fetal antigen 1 (FA1), a circulating member of the epidermal growth factor (EGF) superfamily: ELISA development, physiology and metabolism in relation to renal function. Clin Chim Acta 268:1-20
27. Bachmann E, Krogh TN, Hojrup P, Skjodt K, Teisner B 1996 Mouse fetal antigen 1 (mFA1), the circulating gene product of mdlk, pref-1 and SCP-1: isolation, characterization and biology. J Reprod Fertil 107:279-285
28. Yevtodiyenko A, Schmidt JV 2006 Dlk1 expression marks developing endothelium and sites of branching morphogenesis in the mouse embryo and placenta. Dev Dyn 235:1115-1123
29. Floridon C, Jensen CH, Thorsen P, Nielsen O, Sunde L, Westergaard JG, Thomsen SG, Teisner B 2000 Does fetal antigen 1 (FA1) identify cells with regenerative, endocrine and neuroendocrine potentials? A study of FA1 in embryonic, fetal, and placental tissue and in maternal circulation. Differentiation 66:49-59
30. Tornehave D, Jansen P, Teisner B, Rasmussen HB, Chemnitz J, Moscoso G 1993 Fetal antigen 1 (FA1) in the human pancreas: cell type expression, topological and quantitative variations during development. Anat Embryol (Berl) 187:335-341
31. Sondergaard M, Dagnaes-Hansen F, Flyvbjerg A, Jensen TG 2003 Normalization of growth in hypophysectomized mice using hydrodynamic transfer of the human growth hormone gene. Am J Physiol Endocrinol Metab 285:E427-E432
32. Gill DR, Smyth SE, Goddard CA, Pringle IA, Higgins CF, Colledge WH, Hyde SC 2001 Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1α promoter. Gene Ther 8:1539-1546
33. Dagnaes-Hansen F, Holst HU, Sondergaard M, Vorup-Jensen T, Flyvbjerg A, Jensen UB, Jensen TG 2002 Physiological effects of human growth hormone produced after hydrodynamic gene transfer of a plasmid vector containing the human ubiquitin promotor. J Mol Med 80:665-670
34. Vorup-Jensen T, Jensen UB, Liu H, Kawasaki T, Uemura K, Thiel S, Dagnaes-Hansen F, Jensen TG 2001 Tail-vein injection of mannan-binding lectin DNA leads to high expression levels of multimeric protein in liver. Mol Ther 3:867-874
35. Jensen CH, Jauho EI, Santoni-Rugiu E, Holmskov U, Teisner B, Tygstrup N, Bisgaard HC 2004 Transit-amplifying ductular (oval) cells and their hepatocytic progeny are characterized by a novel and distinctive expression of delta-like protein/preadipocyte factor 1/fetal antigen 1. Am J Pathol 164:1347-1359
36. Flyvbjerg A, Kessler U, Dorka B, Funk B, Orskov H, Kiess W 1992 Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats. Diabetologia 35:589-593
37. Ding M, Odgaard A, Hvid I 1999 Accuracy of cancellous bone volume fraction measured by micro-CT scanning. J Biomech 32:323-326
38. Hildebrand T, Ruegsegger P 1997 Quantification of bone microarchitecture with the structure model index. Comput Methods Biomech Biomed Engin 1:15-23
39. Hansen LH, Madsen B, Teisner B, Nielsen JH, Billestrup N 1998 Characterization of the inhibitory effect of growth hormone on primary preadipocyte differentiation. Mol Endocrinol 12:1140-1149
40. Ding M, Danielsen CC, Hvid I 2006 Age-related three-dimensional microarchitectural adaptations of subchondral bone tissues in guinea pig primary osteoarthrosis. Calcif Tissue Int 78:113-122
41. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610
42. Gerharz EW, Gasser JA, Mosekilde L, Moniz C, Sitter H, Barth PJ, Thomsen JS, Ransley PG, Riedmiller H, Woodhouse CR 2003 Skeletal growth and long-term bone turnover after enterocystoplasty in a chronic rat model. BJU Int 92:306-313
43. Larsen JB, Jensen CH, Schroder HD, Teisner B, Bjerre P, Hagen C 1996 Fetal antigen 1 and growth hormone in pituitary somatotroph cells. Lancet 347:191
44. Andersen M, Jensen CH, Stoving RK, Larsen JB, Schroder HD, Teisner B, Hagen C 2001 Fetal antigen 1 in healthy adults and patients with pituitary disease: relation to physiological, pathological, and pharmacological GH levels. J Clin Endocrinol Metab 86:5465-5470
45. Wolff JA, Budker V 2005 The mechanism of naked DNA uptake and expression. Adv Genet 54:3-20
46. Jensen CH, Schroder HD, Teisner B, Laursen I, Brandrup F, Rasmussen HB 1999 Fetal antigen 1, a member of the epidermal growth factor superfamily, in neurofibromas and serum from patients with neurofibromatosis type 1. Br J Dermatol 140:1054-1059
47. Harken JC, Drivsholm L, Laursen I, Teisner B 1999 Elevated serum levels of fetal antigen 1, a member of the epidermal growth factor superfamily, in patients with small cell lung cancer. Tumour Biol 20:256-262
48. Smas CM, Sul HS 1993 Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell 73:725-734
49. Smas CM, Sul HS 1997 Molecular mechanisms of adipocyte differentiation and inhibitory action of pref-1. Crit Rev Eukaryot Gene Expr 7:281-298
50. Zhang Y, Jiang J, Black RA, Baumann G, Frank SJ 2000 Tumor necrosis factor-α converting enzyme (TACE) is a growth hormone binding protein (GHBP) sheddase: the metalloprotease TACE/ADAM-17 is critical for (PMA-induced) GH receptor proteolysis and GHBP generation. Endocrinology 141:4342-4348
51. Zhou YT, Wang ZW, Higa M, Newgard CB, Unger RH 1999 Reversing adipocyte differentiation: implications for treatment of obesity. Proc Natl Acad Sci USA 96:2391-2395
52. Shimomura I, Shimano H, Korn BS, Bashmakov Y, Horton JD 1998 Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J Biol Chem 273:35299-35306
53. Hordijk R, Wierenga H, Scheffer H, Leegte B, Hofstra RM, Stolte-Dijkstra I 1999 Maternal uniparental disomy for chromosome 14 in a boy with a normal karyotype. J Med Genet 36:782-785
54. Sutton VR, Shaffer LG 2000 Search for imprinted regions on chromosome 14: comparison of maternal and paternal UPD cases with cases of chromosome 14 deletion. Am J Med Genet 93:381-387
55. Laborda J 2000 The role of the epidermal growth factor-like protein dlk in cell differentiation histology and histopathology 15:119-129
56. Abdallah BM, Boissy P, Tan Q, Dahlgaard J, Traustadottir GA, Kupisiewicz K, Laborda J, Delaisse JM, Kassem M 2007 dlk1/FA1 regulates the function of human bone marrow mesenchymal stem cells by modulating gene expression of pro-inflammatory cytokines and immune response-related factors. J Biol Chem 282:7339-7351
57. Bauer SR, Ruiz-Hidalgo MJ, Rudikoff EK, Goldstein J, Laborda J 1998 Modulated expression of the epidermal growth factor-like homeotic protein dlk influences stromal-cell-pre-B-cell interactions, stromal cell adipogenesis, and pre-B-cell interleukin-7 requirements. Mol Cell Biol 18:5247-5255
58. Doggett KL, Briggs JA, Linton MF, Fazio S, Head DR, Xie J, Hashimoto Y, Laborda J, Briggs RC 2002 Retroviral mediated expression of the human myeloid nuclear antigen in a null cell line upregulates Dlk1 expression. J Cell Biochem 86:56-66
59. Shapses SA, Riedt CS 2006 Bone, body weight, and weight reduction: what are the concerns? J Nutr 136:1453-1456
60. Legroux-Gerot I, Vignau J, Collier F, Cortet B 2005 Bone loss associated with anorexia nervosa. Joint Bone Spine 72:489-495
61. Friedrichsen BN, Carlsson C, Moldrup A, Michelsen B, Jensen CH, Teisner B, Nielsen JH 2003 Expression, biosynthesis and release of preadipocyte factor-1/delta-like protein/fetal antigen-1 in pancreatic beta-cells: possible physiological implications. J Endocrinol 176:257-266